Senators Introduce Bipartisan Legislation to Expand Access to Treatment for Patients with Rare, Life-Threatening Diseases
May 29, 2024
May 29, 2024
WASHINGTON, May 29 -- Sen. Kevin Cramer, R-North Dakota, issued the following news release:
BISMARCK - Thousands of Americans struggling with rare and life-threatening diseases are stuck waiting for new cures to make their way through the U.S. Food and Drug Administration's (FDA) arduous approval process. This unfair delay often leaves patients with terminal or untreatable diagnosis with no options. But by creating conditional pathways to expedite treatment options, barriers to time . . .
BISMARCK - Thousands of Americans struggling with rare and life-threatening diseases are stuck waiting for new cures to make their way through the U.S. Food and Drug Administration's (FDA) arduous approval process. This unfair delay often leaves patients with terminal or untreatable diagnosis with no options. But by creating conditional pathways to expedite treatment options, barriers to time . . .